Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The underlying molecular basis of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is not well understood. Characterized by chronic, unexplained fatigue, a disabling payback following exertion (“post-exertional malaise”), and variably presenting multi-system symptoms, ME/CFS is a complex disease, which demands a concerted biomedical investigation from disparate fields of expertise. ME/CFS research and patient treatment have been challenged by the lack of diagnostic biomarkers and finding these is a prominent direction of current work. Despite these challenges, modern research demonstrates a tangible biomedical basis for the disorder across many body systems. This evidence is mostly comprised of disturbances to immunological and inflammatory pathways, autonomic and neurological dysfunction, abnormalities in muscle and mitochondrial function, shifts in metabolism, and gut physiology or gut microbiota disturbances. It is possible that these threads are together entangled as parts of an underlying molecular pathology reflecting a far-reaching homeostatic shift. Due to the variability of non-overlapping symptom presentation or precipitating events, such as infection or other bodily stresses, the initiation of body-wide pathological cascades with similar outcomes stemming from different causes may be implicated in the condition. Patient stratification to account for this heterogeneity is therefore one important consideration during exploration of potential diagnostic developments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822 · cited 1×
“Further, the linkage of cortisol-driven stress responses to the gut through the hypothalamic-pituitary-adrenal (HPA) axis [168] could be dysfunctional in ME/CFS due to the hypocortisolism previously suggested to play a role in the condition [169,170].”
BackgroundCani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 1×
“While the translocation of immunogenic LPS into the bloodstream is generally associated with body-wide inflammation [160,161], it may also lead to the elevation of proinflammatory elements and the stress hormone cortisol in the brain [162].”
BackgroundWallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781 · cited 1×
“Calcium signaling is crucial to immune cell function [77] and is tied to the mitochondria and endoplasmic reticulum as hubs of regulatory control and calcium storage [78].”
BackgroundThe role of gut microbiota in immune homeostasis and autoimmunity
Wu, H.-J., & Wu, E. (2012) · Gut Microbes · doi:10.4161/gmic.19320 · Cited by 1,426
The AMP‐Activated Protein Kinase: Fuel Gauge of the Mammalian Cell?
Hardie, D. G., & Carling, D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00259.x · Cited by 1,317
Mitochondria and the Autophagy–Inflammation–Cell Death Axis in Organismal Aging
Green, D. R., Galluzzi, L., & Kroemer, G. (2011) · Science · doi:10.1126/science.1201940 · Cited by 1,245 · cited 1×
“The mitochondria can partake in activation or suppression of inflammation indirectly by regulating autophagy, which in turn bears downstream regulatory consequences for the activation of inflammation [191].”
BackgroundCarruthers, B. M., Jain, A. K., De Meirleir, K. L., Peterson, D. L., Klimas, N. G., Lerner, A. M., Bested, A. C., Flor-Henry, P., Joshi, P., Powles, A. C. P., et al. (2003) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v11n01_02 · Cited by 1,180 · cited 1×
“Also in usage are the Canadian Consensus Criteria [3] and International Consensus Criteria [4], which mandate PEM for a diagnosis of ME/CFS and therefore may be considered more specific definitions.”
MethodA report—Chronic fatigue syndrome: Guidelines for research
Sharpe, M. C. (1991) · Journal of the Royal Society of Medicine · doi:10.1177/014107689108400224 · Cited by 1,026 · cited 2×
“Case definitions, such as the commonly termed Oxford [1] or Fukuda [2] criteria, are most often utilized throughout the UK and USA, respectively, yet may fail to discriminate between generalized chronic fatigue and ME/CFS which specifically also involves PEM, which aids in characterizing this disorder as a discrete cl…”
BackgroundInfluentialWinder, W. W., & Hardie, D. G. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e299 · Cited by 799 · cited 1×
“ACC, however, is a primary regulatory target of AMPK and is inactivated by phosphorylation when AMPK is activated [61].”
BackgroundRole of gut microbiota-generated short-chain fatty acids in metabolic and cardiovascular health
Chambers, E. S., Preston, T., Frost, G., & Morrison, D. J. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0248-8 · Cited by 691 · cited 1×
“Additionally, many studies have demonstrated a link between the gut microbiota and host mitochondrial function or metabolism with disturbances in one resulting in subsequent dysfunction in the other [131-136].”
BackgroundAaron, L. A., Burke, M. M., & Buchwald, D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.2.221 · Cited by 607 · cited 1×
“This is accompanied by physiological gut abnormalities, such as impaired motility [122], elevated intestinal wall permeability [103,104,123,124], and IBS comorbidity [31,125,126], which has been proposed to comprise part of a ME/CFS subtype [30].”
BackgroundRao, A. V., Bested, A. C., Beaulne, T. M., Katzman, M. A., Iorio, C., Berardi, J. M., & Logan, A. C. (2009) · Gut Pathogens · doi:10.1186/1757-4749-1-6 · Cited by 577
Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome
Papadopoulos, A. S., & Cleare, A. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.153 · Cited by 280 · cited 1×
“Autonomic and hormonal dysregulation • Vasomotor abnormalities [165,185], hypocortisolism [169,170], broad HPA axis disturbance [186,187].”
BackgroundMartich, G. D., Boujoukos, A. J., & Suffredini, A. F. (1993) · Immunobiology · doi:10.1016/s0171-2985(11)80353-0 · Cited by 275 · cited 1×
“While the translocation of immunogenic LPS into the bloodstream is generally associated with body-wide inflammation [160,161], it may also lead to the elevation of proinflammatory elements and the stress hormone cortisol in the brain [162].”
BackgroundTak, L. M., Cleare, A. J., Ormel, J., Manoharan, A., Kok, I. C., Wessely, S., & Rosmalen, J. G. M. (2011) · Biological Psychology · doi:10.1016/j.biopsycho.2011.02.002 · Cited by 230 · cited 2×
“Autonomic and hormonal dysregulation • Vasomotor abnormalities [165,185], hypocortisolism [169,170], broad HPA axis disturbance [186,187].”
BackgroundAbuaita, B. H., Schultz, T. L., & O’Riordan, M. X. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.10.005 · Cited by 223 · cited 1×
“For example, the generation of excess free radicals, which occurs in the mitochondria [143], has been proposed to form part of a microbial defense mechanism [144-146], with enteric species such as Escherichia coli highly susceptible to the bactericidal properties of free radical derived reactive nitrogen species (RNS)…”
BackgroundFluge, Ø., Mella, O., Bruland, O., Risa, K., Dyrstad, S. E., Alme, K., Rekeland, I. G., Sapkota, D., Røsland, G. V., Fosså, A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.89376 · Cited by 209
Maes, M., Mihaylova, I., & Leunis, J.-C. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.021 · Cited by 197
Microbiota-mitochondria inter-talk: Consequence for microbiota-host interaction
Saint-Georges-Chaumet, Y., & Edeas, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftv096 · Cited by 176
Chronic fatigue syndrome and circulating cytokines: A systematic review
Blundell, S., Ray, K. K., Buckland, M., & White, P. D. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.07.004 · Cited by 159 · cited 1×
“Inflammation and cytokines • Inconsistent molecular evidence [102,182], yet is likely to play a role based on clinical presentation and the many reported disturbances in related systems.”
BackgroundGut inflammation in chronic fatigue syndrome
Lakhan, S. E., & Kirchgessner, A. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-79 · Cited by 143 · cited 2×
“For example, the elevated oxidative stress reported in the disorder [148–153] may be entangled with perturbed immune-inflammatory pathways [175–178], gut inflammation [158], and dysfunctional mitochondria.”
BackgroundShukla, S. K., Cook, D., Meyer, J., Vernon, S. D., Le, T., Clevidence, D., Robertson, C. E., Schrodi, S. J., Yale, S., & Frank, D. N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145453 · Cited by 137
Nagy-Szakal, D., Barupal, D. K., Lee, B., Che, X., Williams, B. L., Kahn, E. J. R., Ukaigwe, J. E., Bateman, L., Klimas, N. G., Komaroff, A. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28477-9 · Cited by 120 · cited 7×
“What could be taken from both lines of approach—supported by data from other similar studies [6,13,31] and one cell culture study [41]—is that there may be some manner of TCA cycle disturbance in ME/CFS, possibly one that is substrate supply-driven.”
BackgroundResultInfluentialPowering the Immune System: Mitochondria in Immune Function and Deficiency
Walker, M. A., Volpi, S., Sims, K. B., Walter, J. E., & Traggiai, E. (2014) · Journal of Immunology Research · doi:10.1155/2014/164309 · Cited by 83 · cited 1×
“Furthermore, immunological dysfunction is common in conditions which are primarily mitochondrial diseases [192].”
BackgroundCraddock, T. J. A., Fritsch, P., Rice, M. A., del Rosario, R. M., Miller, D. B., Fletcher, M. A., Klimas, N. G., & Broderick, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084839 · Cited by 75 · cited 4×
“Such an altered state could interact with the previously suggested HPA dysregulation [34] and contribute to the perpetuation of an alternative resting homeostasis.”
BackgroundResultInfluentialBradley, A. S., Ford, B., & Bansal, A. S. (2013) · Clinical and Experimental Immunology · doi:10.1111/cei.12043 · Cited by 73 · cited 1×
“This would be concordant with other reports of elevated naïve and transitional B cells in patients, which may suggest autoimmune tendencies [108].”
ResultAre current chronic fatigue syndrome criteria diagnosing different disease phenotypes?
Maclachlan, L., Watson, S., Gallagher, P., Finkelmeyer, A., Jason, L. A., Sunnquist, M., & Newton, J. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186885 · Cited by 22
Cited by
Eccles, J. A., Thompson, B., Themelis, K., Amato, M. L., Stocks, R., Pound, A., Jones, A.-M., Cipinova, Z., Shah-Goodwin, L., Timeyin, J., et al. (2021) · Clinical Medicine · doi:10.7861/clinmed.2020-0743 · Cited by 55
Khanpour Ardestani, S., Karkhaneh, M., Stein, E., Punja, S., Junqueira, D. R., Kuzmyn, T., Pearson, M., Smith, L., Olson, K., & Vohra, S. (2021) · Medicina · doi:10.3390/medicina57070652 · Cited by 30
Kim, D.-Y., Lee, J.-S., & Son, C.-G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113463 · Cited by 24
Metadata
- Authors
- Missailidis, D., Annesley, S. J., & Fisher, P. R.
- Venue
- Diagnostics
- Publisher
- MDPI AG
- Published
- 2019-07-20
- Volume
- 9
- Issue
- 3
- Pages
- 80
- ISSN
- 2075-4418 (ISSN-L)
- OpenAlex
- W2959063900
- Cited by
- 120
- References
- 31
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.